HomeNews

News

  • New guidelines for starting MS treatment early and switching issued at AAN 2018

    • April 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • AOBiome initiates Ph 2 trial for episodic migraine

    • April 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Strong clinical data with single dose rimegepant in acute treatment of migraine announced by Biohaven

    • April 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Switches from Injectables to Fingolimod associated with lower relapse risks, underlines new study

    • April 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NDA submitted for Brexanolone in Postpartum Depression by Sage Therapeutics

    • April 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Promius to present data from Migraine MAST study at AAN 2018

    • April 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments

    MAST seeks to shed light on the current state of migraine symptom characteristics and illustrate the state of migraine treatment.

    read more

  • Novartis updates Launch Timeline for Advair Copy to 2019

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Japan’s Takeda sweetens $62 billion Shire offer

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Brain Injury increases Parkinson’s risk, claims a latest study

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Amyloid blood biomarker detects Alzheimer’s disease

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more